Fmr LLC Sells 20,702 Shares of SIGA Technologies, Inc. (NASDAQ:SIGA)

Fmr LLC decreased its position in shares of SIGA Technologies, Inc. (NASDAQ:SIGA) by 53.4% during the 3rd quarter, HoldingsChannel reports. The fund owned 18,076 shares of the company’s stock after selling 20,702 shares during the period. Fmr LLC’s holdings in SIGA Technologies were worth $122,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of SIGA. Larson Financial Group LLC bought a new stake in shares of SIGA Technologies in the third quarter worth $30,000. DekaBank Deutsche Girozentrale bought a new stake in SIGA Technologies during the 2nd quarter valued at $40,000. AQR Capital Management LLC bought a new position in SIGA Technologies in the 2nd quarter valued at about $99,000. Zurcher Kantonalbank Zurich Cantonalbank raised its position in SIGA Technologies by 38.9% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 13,684 shares of the company’s stock valued at $104,000 after buying an additional 3,829 shares during the last quarter. Finally, China Universal Asset Management Co. Ltd. boosted its holdings in SIGA Technologies by 64.3% during the third quarter. China Universal Asset Management Co. Ltd. now owns 13,727 shares of the company’s stock worth $93,000 after purchasing an additional 5,372 shares during the last quarter. Institutional investors and hedge funds own 55.40% of the company’s stock.

SIGA Technologies Stock Performance

NASDAQ:SIGA opened at $5.91 on Monday. The firm has a market cap of $422.00 million, a price-to-earnings ratio of 4.93 and a beta of 0.89. The firm has a 50-day moving average price of $6.76 and a two-hundred day moving average price of $7.73. SIGA Technologies, Inc. has a 52 week low of $4.26 and a 52 week high of $12.83.

SIGA Technologies (NASDAQ:SIGA) last released its earnings results on Thursday, November 7th. The company reported $0.02 earnings per share (EPS) for the quarter. The business had revenue of $10.01 million during the quarter. SIGA Technologies had a return on equity of 49.06% and a net margin of 49.33%. As a group, sell-side analysts forecast that SIGA Technologies, Inc. will post 1.04 earnings per share for the current year.

SIGA Technologies Profile

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.